Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-09

Clinical Trial Update: Purified Inactivated Japanese Encephalitis Vaccine [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a purified inactivated Japanese Encephalitis vaccine targeting Japanese Encephalitis Virus Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Purified Inactivated Japanese Encephalitis Vaccine (Purified Inactivated Japanese Encephalitis Vaccine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Japanese Encephalitis Virus Disease | Phase 3 | Status: UNKNOWN